Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors
1998
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
2014 Standout
Cochrane Database of Systematic Reviews
2003 Standout
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
2007 Standout
Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy
2003
The IS4 family of insertion sequences: evidence for a conserved transposase motif
1993
Serogroup B meningococcal vaccines—an unfinished story
2010
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
2010
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness
2006
Antibody Persistence 3 Years after Immunization of Adolescents with Quadrivalent Meningococcal Conjugate Vaccine
2006
Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
2016 Standout
Diagnostic test for etiologic agents of community-acquired pneumonia
2004
Insertion of a novel DNA sequence, IS 1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis
1994
Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands
2002
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
2003 Standout
Evaluation of diagnostic tests for influenza in a pediatric practice
2002
Bacteriophage resistance mechanisms
2010 Standout
Juvenile idiopathic arthritis
2007 Standout
Colonization rate of bacteria in the throat of healthy infants
2002
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine
2003
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness
2008 Standout
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
2004 Standout
Phase I/II, Open-Label Trial of Safety and Immunogenicity of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Human Immunodeficiency Virus-Infected Adolescents
2010
Early Management of Suspected Bacterial Meningitis and Meningococcal Septicaemia in Adults
2003
Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia
2005
How to compare the efficacy of conjugate vaccines to prevent acute otitis media?
2009
Genetic Basis for Biosynthesis, Structure, and Function of Meningococcal Lipooligosaccharide (Endotoxin)
1998
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
2006
The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
2008
Epidemiology of Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Infections in the United States, 1995-1998<SUBTITLE>Opportunities for Prevention in the Conjugate Vaccine Era</SUBTITLE>
2001
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
2004 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells
1999
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009
Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant: Proteomic and immunological comparison with detergent‐derived outer membrane vesicles
2006
Reverse vaccinology: a genome-based approach for vaccine development
2002
Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children
2001
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
2009 Standout
Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults That Is Overcome by Meningococcal C Conjugate Vaccine
2000
Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
2020
The role of nasal carriage in Staphylococcus aureus infections
2005 Standout
Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
2007
Functional Relationships of the Genetic Locus Encoding the Glycosyltransferase Enzymes Involved in Expression of the Lacto-N-neotetraose Terminal Lipopolysaccharide Structure in Neisseria meningitidis
1996
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
2010 StandoutNobel
Acute bacterial meningitis in adults: Predictors of outcome
2009
Plasmids plP419 and plP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements
1995
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
<p>Mechanistic research holds promise for bacterial vaccines and phage therapies for <em>Pseudomonas aeruginosa</em></p>
2019
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
2013
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Disordered Microbial Communities in Asthmatic Airways
2010 Standout
Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?
2008
The Nose As Bacterial Reservoir: Important Differences Between the Vestibule and Cavity
2000
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: Apropos of 1400 children sampled
2001
Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria
1995
Cerebrospinal Fluid Penetration of Levofloxacin in Patients with Spontaneous Acute Bacterial Meningitis
2001
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis
1996
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
2009
Carried Meningococci in the Czech Republic: a Diverse Recombining Population
2002
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
2002 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Bacillus thuringiensis and Its Pesticidal Crystal Proteins
1998 Standout
The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence
1995
Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia
2005
Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes
1994
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population
1994
Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms
1998 Standout
Sexual reproduction as an adaptation to resist parasites (a review).
1990
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
Carried Meningococci in the Czech Republic: a Diverse Recombining Population
2000
Contamination and Sensitivity Issues with a Real-Time Universal 16S rRNA PCR
2000
Common themes in microbial pathogenicity revisited
1997 Standout
Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK)
1996
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
The role of Dam methylation in phase variation of Haemophilus influenzae genes involved in defence against phage infection
2005
Activation of Human Dendritic Cells Is Modulated by Components of the Outer Membranes ofNeisseria meningitidis
2003
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Antibody Avidity and Immunoglobulin G Isotype Distribution following Immunization with a Monovalent Meningococcal B Outer Membrane Vesicle Vaccine
2002
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Guidelines for managing acute bacterial meningitis in adults
2000
eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data
2004 Standout
Human Infection withFusobacterium necrophorum(Necrobacillosis), with a Focus on Lemierre's Syndrome
2007
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
2010 Standout
Performance of the Binax NOW Streptococcus pneumoniae Urinary Antigen Assay for Diagnosis of Pneumonia in Children with Underlying Pulmonary Diseases in the Absence of Acute Pneumococcal Infection
2004
Lipopolysaccharide Endotoxins
2002 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Comparison of Two Urinary Antigen Tests for Establishment of Pneumococcal Etiology of Adult Community-Acquired Pneumonia
2004
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The impact of successive infections on the lung microenvironment
2007
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China
1992
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
2012 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Revaccination of Children after Completion of Standard Chemotherapy for Acute Leukemia
2007
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
The lipooligosaccharide (LOS) of Neisseria meningitidis Serogroup B Strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4′-phosphate substituent
1998
Detection of Streptococcus pneumoniae Antigen in Bronchoalveolar Lavage Fluid Samples by a Rapid Immunochromatographic Membrane Assay
2005
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species
1999
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients
2020
Conceptual issues in local adaptation
2004 Standout
Works of Keith Cartwright being referenced
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
1987
Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom
2002
Meningococcal carriage in close contacts of cases
1991
The Stonehouse study: secretor status and carriage of Neisseria species
1989
An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey
1987
The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis
1992
Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults
1999
Influenza A and meningococcal disease
1991
Dynamics of Carriage of Neisseria meningitidis in a Group of Military Recruits: Subtype Stability and Specificity of the Immune Response following Colonization
1998
Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants
2002
Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers
2001
Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory
1999
Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
1999
Identification and characterization of a novel insertion sequence, IS1106, downstream of the porA gene in B15 Neisseria meningitidis
1992
Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants
2000
Invasive pneumococcal infection in South and West England
1998
Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine
2000
Standardisation and Validation of Serological Assays for the Evaluation of Immune Responses to Neisseria meningitidis Serogroup A and C Vaccines
2000
Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom
2003
Risk factors for meningococcal disease: a case control study in south west England
1988
Immunogenicity and Boosting After a Reduced Number of Doses of a Pneumococcal Conjugate Vaccine in Infants and Toddlers
2006
Rapid Diagnosis of Bacteremic Pneumococcal Infections in Adults by Using the Binax NOW Streptococcus pneumoniae Urinary Antigen Test: a Prospective, Controlled Clinical Evaluation
2003
Neisseria lactamica Protects against Experimental Meningococcal Infection
2002
Diagnosis of invasive pneumococcal infection by PCR amplification of Streptococcus pneumoniae genomic fragments in blood: a multi-centre comparative study.
2003